Dissertation: New method to diagnose inflammatory bowel disease
Shno Asad, PhD Student at Uppsala University's Department of Pharmacy, defends her thesis: Magnetic nanoparticles for diagnosis of inflammatory bowel disease, a work in which she has developed a nano-based technology enabling safer diagnosis of inflammatory bowel disease.
Chronic inflammatory bowel diseases pose complex challenges for patients and healthcare alike. Today, invasive procedures are required to identify where in the intestine an inflammation is and how active it is. For adult patients, this is a painful process, and for children, hazardous anesthesia awaits, after which available treatments are at best able to ease these painful, limiting and often stigmatizing diseases.
At the Department of Pharmacy, work is underway with the goal to develop new methods for safer and more effective ways to diagnose inflammatory bowel disease, and in a current thesis, PhD student Shno Asad identifies biomarkers that indicate inflammatory bowel disease. Within her project, Shno Asad has also developed an antibody-conjugated nanoparticle, making it possible to, via magnetic camera, both locate where the intestinal inflammation is and its degree of activity, information needed to provide patients the right drug at the right time.
Fredag 22 maj Shno Asad defends her thesis at Uppsala’s Biomedical Center. Opponent is Bruno Sarmento, Prinicpal Investigator, University of Porto.
RESEARCHER BIO
Shno Asad received her pharmacuetical education with a master's degree in chemistry at the University of Gothenburg. Shno began her doctoral studies at Uppsala University when she, in autumn 2019, was recruited to Associate Professor Alexandra Teleki's research group in drug delivery.